Source link : https://www.newshealth.biz/health-news/post-remission-skip-stem-cell-transplant/
Patients with mantle cell lymphoma (MCL) who show undetectable minimal residual disease (MRD) after initial treatment with chemotherapy show no significant overall or progression-free survival benefit from subsequent stem cell transplantation compared with those receiving maintenance therapy alone, new research shows. “[These findings] could be practice-changing, because over 70% of patients in the study were […]
Author : News Health
Publish date : 2024-12-19 15:06:00
Copyright for syndicated content belongs to the linked Source.